XENON PHARMACEUTICALS INC's ticker is XENE and the CUSIP is 98420N105. A total of 175 filers reported holding XENON PHARMACEUTICALS INC in Q2 2023. The put-call ratio across all filers is 1.28 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $664 | +22.3% | 18,562 | +34.9% | 0.07% | -1.5% |
Q4 2022 | $543 | -99.4% | 13,763 | +2.8% | 0.07% | +1016.7% |
Q1 2016 | $94,000 | -69.1% | 13,384 | -64.6% | 0.01% | -60.0% |
Q4 2015 | $304,000 | -44.2% | 37,791 | -42.7% | 0.02% | -44.4% |
Q3 2015 | $545,000 | +42.3% | 65,941 | +98.4% | 0.03% | +80.0% |
Q2 2015 | $383,000 | +85.0% | 33,244 | +170.3% | 0.02% | +87.5% |
Q1 2015 | $207,000 | – | 12,300 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Ally Bridge Group (NY) LLC | 266,961 | $10,277,999 | 12.45% |
COMMODORE CAPITAL LP | 1,845,000 | $71,032,500 | 7.98% |
Altium Capital Management LP | 228,000 | $8,778,000 | 6.64% |
TLS Advisors LLC | 33,756 | $1,300 | 5.58% |
GREAT POINT PARTNERS LLC | 530,000 | $20,405,000 | 3.99% |
DAFNA Capital Management LLC | 280,538 | $10,800,713 | 2.95% |
Paradigm Biocapital Advisors LP | 989,327 | $38,089,090 | 2.94% |
Nan Fung Group Holdings Ltd | 114,380 | $4,403,630 | 2.81% |
Avoro Capital Advisors LLC | 4,900,000 | $188,650,000 | 2.56% |
Ghost Tree Capital, LLC | 185,000 | $7,122,500 | 2.35% |